These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19734221)

  • 41. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
    Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
    J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
    Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impaired induction of CD27 and CD28 predicts naive CD4 T cell proliferation defects in HIV disease.
    Luciano AA; Lederman MM; Valentin-Torres A; Bazdar DA; Sieg SF
    J Immunol; 2007 Sep; 179(6):3543-9. PubMed ID: 17785788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model.
    Degryse S; de Bock CE; Cox L; Demeyer S; Gielen O; Mentens N; Jacobs K; Geerdens E; Gianfelici V; Hulselmans G; Fiers M; Aerts S; Meijerink JP; Tousseyn T; Cools J
    Blood; 2014 Nov; 124(20):3092-100. PubMed ID: 25193870
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OX40 signals during priming on dendritic cells inhibit CD4 T cell proliferation: IL-4 switches off OX40 signals enabling rapid proliferation of Th2 effectors.
    Kim MY; Bekiaris V; McConnell FM; Gaspal FM; Raykundalia C; Lane PJ
    J Immunol; 2005 Feb; 174(3):1433-7. PubMed ID: 15661901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human resting CD4+ T cells are constitutively inhibited by TGF beta under steady-state conditions.
    Classen S; Zander T; Eggle D; Chemnitz JM; Brors B; Büchmann I; Popov A; Beyer M; Eils R; Debey S; Schultze JL
    J Immunol; 2007 Jun; 178(11):6931-40. PubMed ID: 17513742
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
    Wells AD; Walsh MC; Bluestone JA; Turka LA
    J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Janus kinase 3-deficient T lymphocytes have an intrinsic defect in CCR7-mediated homing to peripheral lymphoid organs.
    García-Zepeda EA; Licona-Limón I; Jiménez-Sólomon MF; Soldevila G
    Immunology; 2007 Oct; 122(2):247-60. PubMed ID: 17521370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distinct effects of Jak3 signaling on alphabeta and gammadelta thymocyte development.
    Eynon EE; Livák F; Kuida K; Schatz DG; Flavell RA
    J Immunol; 1999 Feb; 162(3):1448-59. PubMed ID: 9973401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function.
    Rowell EA; Walsh MC; Wells AD
    J Immunol; 2005 Mar; 174(6):3359-68. PubMed ID: 15749868
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell development and activation in Jak3-deficient mice.
    Baird AM; Thomis DC; Berg LJ
    J Leukoc Biol; 1998 Jun; 63(6):669-77. PubMed ID: 9620658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. IL-21 sustains CD28 expression on IL-15-activated human naive CD8+ T cells.
    Alves NL; Arosa FA; van Lier RA
    J Immunol; 2005 Jul; 175(2):755-62. PubMed ID: 16002671
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Requirement for an initial signal from the membrane-proximal region of the interleukin 2 receptor gamma(c) chain for Janus kinase activation leading to T cell proliferation.
    Nelson BH; McIntosh BC; Rosencrans LL; Greenberg PD
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1878-83. PubMed ID: 9050873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL.
    Manicassamy S; Gupta S; Huang Z; Sun Z
    J Immunol; 2006 Jun; 176(11):6709-16. PubMed ID: 16709830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
    Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
    J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells.
    Kirken RA; Erwin RA; Taub D; Murphy WJ; Behbod F; Wang L; Pericle F; Farrar WL
    J Leukoc Biol; 1999 Jun; 65(6):891-9. PubMed ID: 10380915
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.
    Au-Yeung BB; Smith GA; Mueller JL; Heyn CS; Jaszczak RG; Weiss A; Zikherman J
    J Immunol; 2017 Mar; 198(6):2445-2456. PubMed ID: 28159902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The JAK1 Selective Inhibitor ABT 317 Blocks Signaling Through Interferon-γ and Common γ Chain Cytokine Receptors to Reverse Autoimmune Diabetes in NOD Mice.
    Ge T; Jhala G; Fynch S; Akazawa S; Litwak S; Pappas EG; Catterall T; Vakil I; Long AJ; Olson LM; Krishnamurthy B; Kay TW; Thomas HE
    Front Immunol; 2020; 11():588543. PubMed ID: 33343569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IL-7R alpha gene expression is inversely correlated with cell cycle progression in IL-7-stimulated T lymphocytes.
    Swainson L; Verhoeyen E; Cosset FL; Taylor N
    J Immunol; 2006 Jun; 176(11):6702-8. PubMed ID: 16709829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities.
    Losdyck E; Hornakova T; Springuel L; Degryse S; Gielen O; Cools J; Constantinescu SN; Flex E; Tartaglia M; Renauld JC; Knoops L
    J Biol Chem; 2015 Nov; 290(48):29022-34. PubMed ID: 26446793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.